Free. Unsubscribe any time.
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. filed 6 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 8 transactions and 203,961 shares. 6 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-06-30, came 123 days after the one before it (2026-02-27) and reports 3 transactions against 2 in the filing before it.
- The sales it reports total 30,902 shares, 19,098 fewer than the 50,000 in the filing before it.
- Its 6 plan statements rank 431st of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 6 have more plan statements on file than it and 4 have fewer.
- Its 6 filings on file run from 2025-03-20 to 2026-06-30, and state 3 plan adoption dates, from 2024-04-27 to 2025-10-14.
Trades in Climb Bio, Inc. 8
- Pimblett Emily — 2025-03-20 · S · 1,199 shares
- Pimblett Emily — 2025-06-20 · S · 1,242 shares
- Brennan Aoife — 2025-06-30 · S · 20,618 shares
- Thomas Stephen Basil — 2026-02-12 · S · 90,000 shares
- Thomas Stephen Basil — 2026-02-13 · S · 10,000 shares
- Thomas Stephen Basil — 2026-02-25 · S · 33,687 shares
- Thomas Stephen Basil — 2026-02-26 · S · 16,313 shares
- Brennan Aoife — 2026-06-29 · S · 30,902 shares
Adoption dates in Climb Bio, Inc. 3
- 2024-04-27 — stated in 2 filings
- 2024-08-30 — stated in 2 filings
- 2025-10-14 — stated in 2 filings
Results prints in Climb Bio, Inc. 8
- 2025-01-10
- 2025-03-25
- 2025-05-14
- 2025-08-12
- 2025-11-06
- 2026-03-05
- 2026-05-07
- 2026-08-06
Trades before a print in Climb Bio, Inc. 1
- 5 days before the 2025-03-25 print — 2025-03-20 · S · Pimblett Emily · 1,199 shares
- 7 days before the 2026-03-05 print — 2026-02-26 · S · Thomas Stephen Basil · 16,313 shares
- 8 days before the 2026-03-05 print — 2026-02-25 · S · Thomas Stephen Basil · 33,687 shares
- 20 days before the 2026-03-05 print — 2026-02-13 · S · Thomas Stephen Basil · 10,000 shares
- 21 days before the 2026-03-05 print — 2026-02-12 · S · Thomas Stephen Basil · 90,000 shares
- 38 days before the 2026-08-06 print — 2026-06-29 · S · Brennan Aoife · 30,902 shares
- 43 days before the 2025-08-12 print — 2025-06-30 · S · Brennan Aoife · 20,618 shares
- 53 days before the 2025-08-12 print — 2025-06-20 · S · Pimblett Emily · 1,242 shares
Interval to Climb Bio, Inc.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 3within 10 days
- 5shortest, days
- 0no later print
- Pimblett Emily 2025-03-20 · S · 5 days before the 2025-03-25 print · SVP, Finance & CAO
- Thomas Stephen Basil 2026-02-25 · S · 8 days before the 2026-03-05 print
- Thomas Stephen Basil 2026-02-26 · S · 7 days before the 2026-03-05 print
Adoption dates Climb Bio, Inc. states
- 2024-04-27 in 2 filings
- 2024-08-30 in 2 filings
- 2025-10-14 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on April 27, 2024”
Reported results dates on file
- 2025-01-10
- 2025-03-25
- 2025-05-14
- 2025-08-12
- 2025-11-06
- 2026-03-05
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.